A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens

Bausch & Lomb Incorporated1 site in 1 country66 target enrollmentDecember 2010

ConditionsMyopia

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Myopia
Sponsor: Bausch & Lomb Incorporated
Enrollment: 66
Locations: 1
Primary Endpoint: Visual Acuity
Status: Completed
Last Updated: 11 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lenses developed by Bausch + Lomb.

Registry

clinicaltrials.gov

Start Date

December 2010

End Date

January 2011

Last Updated

11 years ago

Study Type

Interventional

Study Design

Crossover

Sex

All

Investigators

Sponsor

Bausch & Lomb Incorporated

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings.
•Be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.

Exclusion Criteria

•Have worn gas permeable (GP) contact lenses within last 30 days or polymethylmethacrylate (PMMA) lenses within last 3 months.
•Any systemic disease affecting ocular health.
•Using any systemic or topical medications that will affect ocular physiology or lens performance.
•An active ocular disease, any corneal infiltrative response or are using any ocular medications.
•Any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
•Allergic to any component in the study care products.